Meconium Aspiration Syndrome (MAS)

Meconium aspiration syndrome is a serious condition that is caused by aspiration of amniotic fluid containing meconium, leading to complete or partial airway obstruction, chemical pneumonitis, and surfactant dysfunction. This results in severe respiratory distress. It commonly occurs in significant fetal distress and post-term babies – it rarely occurs before 34 weeks of gestation. Under distress, the fetus gasps and aspirates amniotic fluid.

  • Risk factors – mostly causes of fetal hypoxia and distress
    • Post-date births (> 42 weeks of gestation)
    • Maternal diabetes
    • Maternal hypertension
    • Pre-eclampsia
    • Oligohydramniois
    • Placental insufficiency
    • Chorioamnionitis
    • Smoking
    • Substance abuse
  • Pathophysiology
    • Fetal distress (hypoxia, acidosis, or infection) triggers vagal stimulation, leading to premature relaxation of the anal sphincter and expulsion of meconium into amniotic fluid
    • Gasping respiratory movements caused by hypoxia cause aspiration of meconium-stained liquor into the lungs
    • Meconium can cause complete or partial obstruction of the airway
      • Complete obstruction = absorption atelectasis (patchy)
      • Incomplete obstruction = air-trapping and hyperinflation/pneumothorax via ball-valve effect
    • Meconium contains pro-inflammatory substances (bile acids, pancreatic enzymes, cytokines) that directly damage alveolar and bronchial epithelium, triggering severe lung inflammation
    • This inflammation leads to:
      • Alveolar edema and interstitial swelling → Impaired gas exchange
      • Surfactant inactivation → Alveolar collapse (atelectasis)
      • Neutrophilic infiltration → Further lung damage
    • Meconium inhibits nitric oxide (NO) production, leading to pulmonary vasoconstriction and persistent pulmonary hypertension of the newborn (PPHN).
    • This worsens hypoxia, creating a vicious cycle of hypoxic pulmonary vasoconstriction → increased right-to-left shunting via the ductus arteriosus and foramen ovale → systemic hypoxemia and cyanosis
  • Signs and symptoms
    • Coarse breath sounds
    • Wheeze on auscultation
    • Barrel chest appearance due to air trapping and hyperinflation – ball-valve effect of aspirated meconium
    • Meconium stained liquour
    • Meconium-stained nails, skin, and umbilical cord
    • Green urine after birth – pigments are absorbed in the lungs and excreted in urine
    • Hypotonia and diminished reflexes – characteristic of birth asphyxia
  • Investigations
    • Chest X-ray
      • Irregular infiltrates
      • Hyperinflation
      • Lobar consolidation in severe cases
      • Pulmonary air leaks
      • Patchy collapse = complete obstruction
      • Air trapping = incomplete obstruction
    • Arterial blood gases
    • Complete Blood Count: rule out infection as the cause of in-utero stress
  • Treatment
    • Neonatal resuscitation based on status at delivery
    • Suction the nose and mouth
    • Suction the trachea if:
    • Positive pressure ventilation and careful SpO2 monitoring
    • NICU care
    • Insert an umbilical artery catheter to monitor ABGs
    • Monitor Hb
      • Maintain > 13g/dL
    • Surfactant therapy
    • Inhaled Nitric Oxide – a pulmonary vasodilator – to treat the persistent pulmonary hypertension of the newborn (PPHN) that results
  • Complications
    • Chemical pneumonitis
    • Persistent pulmonary hypertension of the newborn
    • Pulmonary air leaks and Pneumothorax
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *